Thirumala-Devi Kanneganti
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
June, 2024
June 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« May
Thirumala-Devi Kanneganti
Jun 16, 2024, 03:40 |
Insight
New research by Thirumala-Devi Kanneganti reveals NLRC5 acts as an innate immune sensor and cell death regulator - St. Jude Research
St. Jude Research shared on X: “New research by Thirumala-Devi Kanneganti in Cell reveals NLRC5…
All:
1
Posts:
1 - 10
Career Journey to President and CEO - OncoInfluencers
New Paper Alert! Long-Term Benefits of Dabrafenib-Trametinib in Stage III Melanoma: 8-Year COMBI-AD Trial Results
We mourn the loss of our Ivy Elkins
FDA grants accelerated approval to adagrasib with cetuximab for KRAS G12C-mutated colorectal cancer
Rob Winn: Honored to receive the ASCO Allen Lichter Visionary Leader Award
Facebook
RSS Feed
Twitter
Linkedin
Youtube